ResearcherUniversitätsmedizin GöttingenActive in the last 2 years
Silke Cameron
Matched on ORCID iD 0000-0003-2761-0960; OpenAlex author ID A5078627364. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2022: 1 paper · 2023: none · 2024: 1 paper
Papers 2
- Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic tra… Last author DOI 10.3389/fonc.2024.1454291↗
- Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer. Co-author DOI 10.1172/jci.insight.154475↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Volker Ellenrieder · 2 shared papers, 2022–2024 · strength 0.35
- Paper Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaiho… DOI 10.3389/fonc.2024.1454291↗
- Paper Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancre… DOI 10.1172/jci.insight.154475↗
- Frauke Alves · 1 shared paper, 2024 · strength 0.23
- Joanna Napp · 1 shared paper, 2024 · strength 0.23
- Elisa Espinet Espinet · 1 shared paper, 2022 · strength 0.12
- H. Carlo Maurer · 1 shared paper, 2022 · strength 0.12
- Shiv K. Singh · 1 shared paper, 2022 · strength 0.12
- Uday Kishore · 1 shared paper, 2022 · strength 0.12
- Andreas Trumpp · 1 shared paper, 2022 · strength 0.12
- Niklas Krebs · 1 shared paper, 2022 · strength 0.12
- Lukas Klein · 1 shared paper, 2022 · strength 0.12
- Mengyu Tu · 1 shared paper, 2022 · strength 0.12
- Albrecht Neeße · 1 shared paper, 2022 · strength 0.12
- Elisabeth Heßmann · 1 shared paper, 2022 · strength 0.12
- Rolf A. Brekken · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.